BSE filing, NSE: JINDALSTEL. Summary written from the filing by ALFA Finder's alert engine.
Jindal Steel Ltd: key numbers
- Share price
- ₹1,048.10
- Market cap
- ₹1,06,915 Cr
- Revenue (annual)
- ₹53,225 Cr
- Net profit (annual)
- ₹3,367 Cr
- P/E (TTM)
- 37.5×Sector 16.9×
- Promoter holding
- 62.69%+0.00% QoQ
- FII holding
- 8.75%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Jindal Steel Ltd
All →Jindal Steel Investor Presentation: Key Takeaways
Q2FY27 gross revenue ₹19,448 cr, adj. EBITDA ₹2,504 cr, PAT ₹771 cr, net debt/EBITDA 1.51x, cash ₹7,237 cr. Deleveraging and capex-led growth continue.
Jindal Steel Q2 FY27 Results: Net Profit ₹770.6 Cr, Up 21.3% YoY
Jindal Steel Ltd reported revenue from operations of ₹16,678 Cr (+42.7% YoY) and net profit of ₹770.6 Cr (+21.3% YoY) for Q2 FY27.
- Key figure
- Net profit ₹770.6 Cr · +21.3% YoY
Jindal Steel Employee Stock Options
Jindal Steel's NRC approved granting 6,75,016 ESOPs to eligible employees under the 2022 scheme. No exercise price or monetary value is stated for the grant.
Jindal Steel Board Meeting Date
Jindal Steel Ltd has scheduled a board meeting for October 23, 2026, to consider and approve its unaudited standalone and consolidated financial results.
Jindal Steel Promoter Buying: ₹9.21 Cr
Promoter group member Sarika Jhunjhnuwala acquired 79,600 equity shares of Jindal Steel via market purchase for ₹9.21 Crore.
- Value
- ₹9.21 Cr
Jindal Steel Promoter Selling: ₹108.2 Cr
Promoter group member Sarika Jhunjhnuwala sold 95,000 equity shares of Jindal Steel Ltd via open market transactions.
- Value
- ₹108.2 Cr
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.